-transparent.png){kind=logo}
The role of renomedullary lipids in the hypotensive effect of captopril was studied in spontaneously hypertensive rats, one-kidney, one clip hypertensive rats and two-kidney, one clip hypertensive rats using inhibitors of acetyl glyceryl ether phosphorylcholine and prostaglandins, and chemical medullectomy. Our experiments indicate that it is unlikely that renomedullary lipids contribute to the hypotensive action of captopril.
Related Publications
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
September 1984,
Life sciences,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
November 1993,
Clinical pharmacology and therapeutics,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
October 1981,
European journal of clinical investigation,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
February 1993,
Journal of cardiovascular pharmacology,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
January 1988,
Kardiologia polska,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
November 1983,
Methods and findings in experimental and clinical pharmacology,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
May 1983,
British medical journal (Clinical research ed.),
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
April 1983,
British medical journal (Clinical research ed.),
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
January 1986,
Clinical and experimental hypertension. Part A, Theory and practice,
S Saeki, and
T Ogihara, and
F Masugi, and
Y Kumahara
January 1985,
Journal of cardiovascular pharmacology,
